Gupta Rishi

Director at Turnstone Biologics Corp. · on record since Jul 24, 2023
10% owner at Turnstone Biologics Corp. · on record since Jul 24, 2023
Director at ChemoCentryx, Inc. · on record since Feb 8, 2012
Director at XNE, Inc. · on record since Oct 28, 2014
10% owner at XNE, Inc. · on record since Oct 28, 2014
Director at Dimension Therapeutics, Inc. · on record since Oct 29, 2015
10% owner at Dimension Therapeutics, Inc. · on record since Oct 29, 2015
Director at Verona Pharma plc · on record since Jan 5, 2021
10% owner at Verona Pharma plc · on record since Jan 5, 2021
Director at Enliven Therapeutics, Inc. · on record since Feb 27, 2023
10% owner at Enliven Therapeutics, Inc. · on record since Feb 27, 2023

Insider trading activity of Gupta Rishi

Transactions on record: 40; since Jun 26, 2012

Open-market buys: 2; $7.6M

Open-market sells: 11; $168.8M

Companies traded: 5; last filing Feb 17, 2026

Figures computed from official regulatory filings — .

Companies where Gupta Rishi has traded

Enliven Therapeutics, Inc.12 tx · $22.9M · Feb 17, 2026
Turnstone Biologics Corp.9 tx · $5M · Aug 8, 2025
Verona Pharma plc12 tx · $145.9M · May 15, 2023
Dimension Therapeutics, Inc.6 tx · $2.6M · May 23, 2016
ChemoCentryx, Inc.1 tx · Jun 26, 2012

Track record of Gupta Rishi

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Gupta Rishi

Co-insiders of Gupta Rishi

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Enliven Therapeutics, Inc.Listing on record	Feb 17, 2026	AwardD (derivative)	1,580	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 17, 2026	AwardD (derivative)	33,989	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Turnstone Biologics Corp.Listing unverified	Aug 8, 2025	Other	-3,099,265	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 10, 2025	AwardD (derivative)	20,491	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Turnstone Biologics Corp.Listing unverified	Jul 2, 2024	AwardD (derivative)	12,770	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	May 20, 2024	Sell	-1,000,000	22.14 USD	$22.1M		SEC
Enliven Therapeutics, Inc.Listing on record	May 20, 2024	Sell	-33,300	22.14 USD	$737.3K		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 20, 2024	AwardD (derivative)	23,364	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 15, 2024	AwardD (derivative)	16,835	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Turnstone Biologics Corp.Listing unverified	Oct 17, 2023	AwardD (derivative)	25,540	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Turnstone Biologics Corp.Listing unverified	Jul 24, 2023	OtherD (derivative)	-229,158	—	n/a (No price was disclosed in the filing)		SEC
Turnstone Biologics Corp.Listing unverified	Jul 24, 2023	OtherD (derivative)	-937,372	—	n/a (No price was disclosed in the filing)		SEC
Turnstone Biologics Corp.Listing unverified	Jul 24, 2023	Other	2,682,599	—	n/a (No price was disclosed in the filing)		SEC
Turnstone Biologics Corp.Listing unverified	Jul 24, 2023	Buy	416,666	12.00 USD	$5M	conv 46First in 12mo	SEC
Turnstone Biologics Corp.Listing unverified	Jul 24, 2023	OtherD (derivative)	-1,249,829	—	n/a (No price was disclosed in the filing)		SEC
Turnstone Biologics Corp.Listing unverified	Jul 24, 2023	OtherD (derivative)	-266,240	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	May 19, 2023	Exercise	2,125	4.28 USD	$9.1K		SEC
Enliven Therapeutics, Inc.Listing on record	May 19, 2023	ExerciseD (derivative)	-2,125	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verona Pharma plcListing unverified	May 15, 2023	Sell	-14,400	21.96 USD	$316.2K		SEC
Verona Pharma plcListing unverified	May 15, 2023	Sell	-345,313	20.00 USD	$6.9M		SEC
Verona Pharma plcListing unverified	May 15, 2023	Sell	-43,200	21.64 USD	$934.8K		SEC
Verona Pharma plcListing unverified	May 15, 2023	Sell	-80,000	22.26 USD	$1.8M		SEC
Verona Pharma plcListing unverified	Apr 28, 2023	AwardD (derivative)	96,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Apr 6, 2023	AwardD (derivative)	27,567	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 27, 2023	Award	7,611,458	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Enliven Therapeutics, Inc.Listing on record	Feb 17, 2026	AwardD (derivative)	1,580	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 17, 2026	AwardD (derivative)	33,989	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Turnstone Biologics Corp.Listing unverified	Aug 8, 2025	Other	-3,099,265	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 10, 2025	AwardD (derivative)	20,491	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Turnstone Biologics Corp.Listing unverified	Jul 2, 2024	AwardD (derivative)	12,770	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	May 20, 2024	Sell	-1,000,000	22.14 USD	$22.1M		SEC
Enliven Therapeutics, Inc.Listing on record	May 20, 2024	Sell	-33,300	22.14 USD	$737.3K		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 20, 2024	AwardD (derivative)	23,364	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 15, 2024	AwardD (derivative)	16,835	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Turnstone Biologics Corp.Listing unverified	Oct 17, 2023	AwardD (derivative)	25,540	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Turnstone Biologics Corp.Listing unverified	Jul 24, 2023	OtherD (derivative)	-229,158	—	n/a (No price was disclosed in the filing)		SEC
Turnstone Biologics Corp.Listing unverified	Jul 24, 2023	OtherD (derivative)	-937,372	—	n/a (No price was disclosed in the filing)		SEC
Turnstone Biologics Corp.Listing unverified	Jul 24, 2023	Other	2,682,599	—	n/a (No price was disclosed in the filing)		SEC
Turnstone Biologics Corp.Listing unverified	Jul 24, 2023	Buy	416,666	12.00 USD	$5M	conv 46First in 12mo	SEC
Turnstone Biologics Corp.Listing unverified	Jul 24, 2023	OtherD (derivative)	-1,249,829	—	n/a (No price was disclosed in the filing)		SEC
Turnstone Biologics Corp.Listing unverified	Jul 24, 2023	OtherD (derivative)	-266,240	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	May 19, 2023	Exercise	2,125	4.28 USD	$9.1K		SEC
Enliven Therapeutics, Inc.Listing on record	May 19, 2023	ExerciseD (derivative)	-2,125	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verona Pharma plcListing unverified	May 15, 2023	Sell	-14,400	21.96 USD	$316.2K		SEC
Verona Pharma plcListing unverified	May 15, 2023	Sell	-345,313	20.00 USD	$6.9M		SEC
Verona Pharma plcListing unverified	May 15, 2023	Sell	-43,200	21.64 USD	$934.8K		SEC
Verona Pharma plcListing unverified	May 15, 2023	Sell	-80,000	22.26 USD	$1.8M		SEC
Verona Pharma plcListing unverified	Apr 28, 2023	AwardD (derivative)	96,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Apr 6, 2023	AwardD (derivative)	27,567	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 27, 2023	Award	7,611,458	—	n/a (No price was disclosed in the filing)		SEC